|
|
Article: United States : Zydus first Indian co to file H1N1 clinical trials.
- Article from:
- TendersInfo
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 Al Bawaba (Middle East) Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: pinto03
The race among Indian pharma companies engaged in swine flu vaccine development may soon throw up a winner just when the pandemic
enters a critical stage with the onset of winter.
Drug Controller General (India) Dr Surindra Singh told ET that the Rs 3,000-crore pharma major Zydus Group has become the first domestic company to file for clinical trial protocol for H1N1 vaccine with the DCGI. With this filing, the Ahmedabad-based major leads other Indian pharma majors including Bharat Biotech, Panacea Biotech and Serum Institute of India, the three entities mandated by the Indian government to develop the vacccine.
...